-
The FDA has approved the first antineoplastic that acts by the inhibiting the formation of new blood vessels in tumors.
-
Use of antibiotics is associated with increased risk of breast cancer and death from breast cancer in a dose-dependent way.
-
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera; Coronary Artery Calcium Score Plus Framingham Score for Risk Prediction; Intra-Articular Hyaluronic Acid in the Treatment of Knee Osteoarthritis
-
The FDA has approved a combination of olanzapine and fluoxetine for the treatment of depressive episodes associated with bipolar disorder.
-
Intranasal fluticasone helps sleep-disordered breathing in patients with allergic rhinitis.
-
New guidelines for the treatment of bacterial rhinosinusitis were published in the January supplement of Otolaryngology-Head and Neck Surgery by the Sinus and Allergy Health Partnership.
-
Use of B-Type Natriuretic Peptide in the Evaluation and Management of
Acute Dyspnea; Association Between C-Reactive Protein and Age-Related Macular Degeneration; VZV Reactivation in Astronauts
-
Shared pathophysiologic mechanisms for migraine, neuropathic pain, and epilepsy underscore the notion that antiepileptic drugs (AED) should be standard treatment for the former. Five new AEDs and their use in these nonepileptic painful disorders are summarized.
-
Increased iron stores (eg, ferritin levels) are associated with an increased risk of type 2 diabetes in women.
-
The first of a class of calcimimetics has been approved by the FDA for the treatment of hyperparathyroidism associated with renal failure and in patients with parathyroid cancer.
